ASCO publishes a suite of peer-reviewed journals with content focused on

  • clinical oncology research;
  • issues and insights affecting oncology practice;
  • cancer care, research, and care delivery issues unique to countries and settings with limited healthcare resources;
  • biomedical informatics methods and processes applied to cancer-related data, information, and images; and
  • the science and practice of precision oncology.

ASCO’s peer-reviewed journals follow a continuous publication schedule. Below is a select list of the newest content from ASCO’s journals. ASCO will update the list on a near-daily basis, and we encourage you to check this page frequently. Email ASCO’s Media Team to request an embargoed journal article or an interview with a study author.

ASCO occasionally highlights select journal articles in an embargoed press release known as a News Digest or in a Featured Article summary. Sign up to receive communications regarding these articles.

Publishing June 16, 2021, 4:00 pm ET:

Therapeutic Implications of Germline Testing in Patients with Advanced Cancers (Original Report) 
Zsofia Stadler, et al. 
Request this article

PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer (Original Report) 
Yoon-Koo Kang, et al. 
Request this article

Monitoring of Circulating Tumor DNA Improves Early Relapse Detection after Axicabtagene Ciloleucel in Large B-cell Lymphoma: Results of a Prospective Multi-Institutional Trial (Original Report) 
David Miklos, et al. 
Request this article

SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed Therapy (Original Contribution) 
Angela DeMichele, et al. 
Request this article

Publishing June 15, 2021, 4:00 pm ET:

Mortgage Lending Bias and Breast Cancer Survival Among Older Women in the United States (Original Report) 
Kirsten Beyer, et al. 
Request this article

Pediatric Brain Tumor Patients: When Do Their Delays Begin? (Editorial) 
Stephen Alan Sands, et al. 
Request this article

C/Can City Engagement Process: An Implementation Framework for Strengthening Cancer Care in Cities in Low- and Middle-Income Countries (Special Article) 
Rebecca Morton Doherty, et al.
 Request this article

Strengthening Pathology Capacity to Deliver Quality Cancer Care in Cities in LMICs (Special Article) 
Silvina Frech, et al. 
Request this article

Clinical Implications of Genomic Loss of Heterozygosity in Endometrial Carcinoma (Original Report) 
Marina Frimer, et al. 
Request this article

Would the Recommended Dose Have Been Different Using Novel Dose-Finding Designs? Comparing Dose-Finding Designs in Published Trials (Original Report) 
Shing Lee, et al. 
Request this article

Published June 14, 2021, 4:00 pm ET:

Randomized, Double-Blind Trial on the Impact of Word Count in Cancer Clinical Trial Consent Forms (Original Contribution) 
Aminah Jatoi, et al. 
Request this article

Published June 11, 2021, 4:00 pm ET:

Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (Rapid Communication)
Paul Richardson, et al. 
Request this article

What the Princess Bride Teaches Us About Outcomes in Multiple Myeloma (Editorial) 
Anita D'Souza, et al. 
Request this article

Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial ( HR-NBL1) (Original Report)
Gudrun Schleiermacher, et al. 
Request this article

Cervical Cancer-Associated Suffering: Estimating the Palliative Care Needs of a Highly Vulnerable Population (Orginal Report) 
Eric Krakauer, et al. 
Request this article

Essential Package of Palliative Care for Women With Cervical Cancer: Responding to the Suffering of a Highly Vulnerable Population (Special Article) 
Eric Krakauer, et al. 
Request this article

Augmented Package of Palliative Care for Women With Cervical Cancer: Responding to Refractory Suffering (Special Article) 
Eric Krakauer, et al. 
Request this article

Published June 10, 2021, 4:00 pm ET:

FOXR2 Stabilizes MYCN Protein and Identifies Non-MYCN-Amplified Neuroblastoma Patients with Unfavorable Outcome (Original Report) 
Felix Schmitt-Hoffner, et al. 
Request this article

A Children’s Oncology Group Phase III Trial of Reduced Dose and Volume Radiotherapy with Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma (Original Report) 
Jeff Michalski, et al. 
Request this article

Summary of the 12 Most Common Cancers in the CancerLinQ Discovery (CLQD) Database (Original Report)
Danielle Potter, et al. 
Request this article

Multigene Panel Testing in Individuals With Hepatocellular Carcinoma Identifies Pathogenic Germline Variants (Original Report) 
Kirk Wangensteen, et al. 
Request this article

Cancer Diagnoses following Abnormal Non-Invasive Prenatal Testing: A Case Series, Literature Review, and Proposed Management Model (Special Article) 
Eryn Dow, et al. 
Request this article

Published June 9, 2021, 4:00 pm ET:

A Biologic Assignment Trial of Reduced Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients Aged 50-75 with Advanced Myelodysplastic Syndrome (Original Report) 
Corey Cutler, et al. 
Request this article

Published June 8, 2021, 4:00 pm ET:

Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score (Original Report)
Peter Kraft, et al. 
Request this article

Paving The Way For Long-Term Survival in Non-Small Cell Lung Cancer (Editorial)
Jordi Remon, et al. 
Request this article

A Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients with Locally Advanced Esophageal Cancer (ARTDECO study) (Original Report) 
Maarten Hulshof, et al. 
Request this article

Levine Cancer Institute Financial Toxicity Tumor Board: A Potential Solution to an Emerging Problem (Original Contribution) 
Derek Raghavan, et al. 
Request this article

Global Radiotherapy: Current Status and Future Directions—White Paper (Special Article)
May Abdel-Wahab, et al. 
Request this article

Cervical Cancer Treatment in HIV-Positive Patients: A Survey of Treatment Practices in India (Original Report) 
Lavanya Gurram, et al. 
Request this article

Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study (Original Report) 
Sudeep Gupta, et al. 
Request this article

Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer (Original Report) 
Lorenzo Gerratana, et al. 
Request this article

Published June 7, 2021, 4:00 pm ET:

Impact of Palliative Care Involvement on End-of-Life Care Patterns Among Adolescents and Young Adults with Cancer: A Population-Based Cohort Study (Original Report)
Alisha Kassam, et al.
Request this article

Payment Methodology for the Radiation Oncology Alternative Payment Model: Implications for Practices and Suggestions for Improvement (Editorial) 
Nikhil Thaker, et al. 
Request this article

Mobile Health Application for Patients Undergoing Breast Cancer Surgery: Feasibility Study (Original Report) 
Jennifer Plichta, et al. 
Request this article

Clinical Inflection Point Detection on the Basis of EHR Data to Identify Clinical Trial–Ready Patients With Cancer (Original Report)
Kenneth Kehl, et al. 
Request this article

Implementing Electronic Patient-Reported Outcomes for Patients With New Oral Chemotherapy Prescriptions at an Academic Site and a Community Site (Original Report)
Meghan Shea, et al. 
Request this article

Machine Learning Methods to Identify Missed Cases of Bladder Cancer in Population-Based Registries (Original Report)
Anne-Michelle Noone, et al. 
Request this article

 

The embargo date and time of a journal article coincide with its online publication date and time. Journalists may conduct embargoed interviews with study authors up to one week prior to the online publication date. ASCO takes embargo violations seriously and violations typically result in the loss of journal media privileges for a period of one year and may affect broader ASCO media privileges as well. Journalists may request embargoed articles. Please direct further questions regarding the embargo policies for ASCO Journals to the Media Team.